CD274 and diffuse large B-cell lymphoma: Our own work has reported that PD-L1 upregulation on lymphoma-educated stromal cells can dampen TIL cytolytic killing activity against DLBCL tumor cells, highlighting that stromal cells expressing inhibitory ligands can directly modulate anti-tumor immune responses (274).